Surgical Innovation Through Hepatic Volume and Function Preservation Techniques

Abstract

Preservation of hepatic volume and function has emerged as a pivotal aspect in modern hepatic surgery, aiming to reduce post-hepatectomy liver failure (PHLF) and improve patient outcomes. Recent advances in surgical innovation, perioperative care, and preoperative assessment have redefined the management of complex liver resections. This review explores epidemiological trends, pathophysiological mechanisms, clinical features, diagnostic modalities, and evidence-based management strategies, with a focus on recent innovations and guideline-based recommendations for hepatic volume and function preservation.

Introduction

Hepatic resection remains the cornerstone therapy for a spectrum of benign and malignant liver diseases. However, the risk of PHLF and the challenge of maintaining sufficient functional liver remnant (FLR) have necessitated the development of innovative surgical techniques aimed at preserving hepatic volume and function. This article provides a comprehensive overview of these advancements, integrating recent evidence, clinical guidelines, and mechanistic insights relevant to practicing hepatobiliary surgeons and multidisciplinary liver teams.

Epidemiology / Disease Burden

Globally, liver cancer ranks among the top causes of cancer-related mortality, with hepatocellular carcinoma (HCC) being the most prevalent primary malignancy. Surgical resection offers curative potential, yet only a subset of patients are eligible due to underlying liver dysfunction, cirrhosis, or insufficient FLR. The incidence of PHLF following major hepatectomy ranges from 5% to 20%, with significant impact on morbidity and mortality. In parallel, the increasing burden of non-alcoholic fatty liver disease (NAFLD) and chronic viral hepatitis has led to more complex hepatic resections, further underscoring the need for volume and function preservation strategies.

Pathophysiology

The liver\'s remarkable regenerative capacity underpins successful surgical outcomes, but is compromised in chronic liver disease and after extensive resection. PHLF is characterized by impaired synthetic, excretory, and detoxification functions, often precipitated by inadequate FLR or subclinical parenchymal dysfunction. Mechanistically, hepatic regeneration involves complex interplay between hepatocyte proliferation, angiogenesis, and extracellular matrix remodeling, all modulated by cytokine and growth factor signaling. The balance between resected and preserved liver volume, as well as the quality of liver parenchyma, critically determines postoperative function.

Risk Factors

Key risk factors for impaired hepatic volume and function post-surgery include small FLR (<25-30% in non-cirrhotic livers, <40% in cirrhotic livers), pre-existing liver disease (e.g., cirrhosis, steatosis, fibrosis), advanced age, malnutrition, and extensive tumor burden. Chemotherapy-associated liver injury, portal hypertension, and comorbidities such as diabetes or obesity further elevate the risk of PHLF. Accurate risk stratification is essential for optimal surgical planning and patient counseling.

Clinical Features

Clinically, PHLF manifests as hyperbilirubinemia, coagulopathy, encephalopathy, ascites, and renal dysfunction in the early postoperative period. The degree of liver dysfunction correlates with the volume and quality of the remnant liver. Early identification of at-risk patients is crucial for timely intervention and improved outcomes.

Diagnosis

Assessment of hepatic volume and function integrates cross-sectional imaging (CT, MRI volumetry) with dynamic liver function tests (e.g., indocyanine green clearance, 99mTc-mebrofenin hepatobiliary scintigraphy). Preoperative volumetric analysis quantifies FLR, while functional imaging assesses regional hepatic function. Intraoperative ultrasound and real-time navigation aid precise demarcation of resection margins. Postoperative monitoring includes serial liver function tests and imaging to detect early signs of PHLF or biliary complications.

Treatment & Management

Management strategies focus on maximizing FLR while ensuring oncological safety. Parenchymal-sparing techniques, such as anatomical segmentectomy and subsegmentectomy, minimize loss of functional tissue. Preoperative portal vein embolization (PVE) or ligation (PVL) induces contralateral hypertrophy, increasing FLR before major hepatectomy. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) offers rapid hypertrophy for select patients. Perioperative optimization, including meticulous hemostasis, avoidance of ischemia-reperfusion injury, and enhanced recovery protocols, further contribute to improved surgical outcomes.

Recent Advances / Emerging Therapies

Innovations in preoperative planning include three-dimensional (3D) reconstruction and simulation for personalized surgical mapping. Novel pharmacological agents, such as growth factor modulators and regenerative therapies, are under investigation to augment liver regeneration. Minimally invasive approaches, including laparoscopic and robotic resections, offer reduced morbidity without compromising oncological efficacy. The use of intraoperative fluorescence imaging enhances vascular and biliary structure identification, facilitating precise parenchymal transection. Hybrid techniques combining PVE with hepatic vein embolization (HVE) have demonstrated promising results in expanding resectability among high-risk patients.

Guideline Recommendations

Recent guidelines from the International Hepato-Pancreato-Biliary Association (IHPBA), European Association for the Study of the Liver (EASL), and American Association for the Study of Liver Diseases (AASLD) emphasize accurate preoperative assessment of FLR and liver function, especially in patients with chronic liver disease. A minimum FLR of 25-30% is recommended for patients with normal livers, while those with compromised parenchyma require 40% or more. PVE or ALPPS should be considered in patients with insufficient FLR. Multidisciplinary evaluation and adherence to enhanced recovery after surgery (ERAS) protocols are advocated to optimize perioperative care and outcomes.

Conclusion

Preserving hepatic volume and function is fundamental to the evolution of liver surgery, significantly impacting patient safety and long-term survival. Through the integration of advanced imaging, innovative surgical techniques, and multidisciplinary perioperative management, the risk of PHLF can be minimized while expanding resectability for complex cases. Continued research into regenerative therapies and functional assessment tools promises to further refine the landscape of hepatic surgery. For the practicing clinician, adherence to evidence-based guidelines and a personalized approach remain the cornerstones of optimal patient care in hepatic surgery.